Chinese banks and insurers boost tech startups with innovative financing, enabling over 7,000 deals worth 88 billion yuan.

Chinese banks and insurers are expanding tailored financial support for tech firms through innovative products like "loans plus equity investment," IP pledge financing, and patent insurance, guided by regulators. Institutions are prioritizing growth potential over traditional metrics, offering unsecured, long-term loans tied to R&D subsidies, especially for startups. A Beijing platform links capital, tech, and talent, helping companies like MicroCyto and Prime Gene Therapeutics secure funding. Over 70,000 tech firms have been recommended to national banks and the National Financing Guarantee Fund, resulting in more than 7,000 financing deals totaling over 88 billion yuan. Pilot programs are advancing IP finance ecosystems and expanding equity investment via financial asset investment companies (AICs) to 18 cities, with China Merchants Bank recently approved to launch its own AIC, joining Industrial and China CITIC Bank.